Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (5)
  • Histone Methyltransferase
    (4)
  • ATG
    (1)
  • ATPase
    (1)
  • Autophagy
    (1)
  • Dehydrogenase
    (1)
  • Epigenetic Reader Domain
    (1)
  • Histone Acetyltransferase
    (1)
  • Histone Demethylase
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

hoxa9

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • Natural Products
    1
    TargetMol | Natural_Products
  • Antibody Products
    1
    TargetMol | Antibody_Products
CCI-007
T8838939228-52-1
CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485
  • $30
In Stock
Size
QTY
DB818
T9958790241-43-9
DB818 is a synthetic Homeobox A9 (HOXA9) inhibitor and can be used for research on the treatment of acute myeloid leukaemia associated with HOXA9 overexpression.
    Inquiry
    Inquiry
    FY-21
    T77583In house
    FY-21 is a selective LSD1 inhibitor (IC50= 340 nM) that inhibits proliferation and colony formation of leukemia cells, decreases mRNA levels of the transcription factors HOXA9 and MEIS1, and can be used in the study of leukemia.
    • $195
    In Stock
    Size
    QTY
    ML390
    T137742029049-79-2
    ML390 exerts its potent differentiation effect on multiple leukemia models.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    Neriifolin
    NSC123976, NSC 123976, 17β-Neriifolin, 17beta-Neriifolin
    T124830466-07-9
    Neriifolin (17β-Neriifolin), a cardiac glycoside extracted from the unripe fruit of Cerbera manghas, is a Na+K+-ATPase inhibitor with anticancer activity that inhibits cell proliferation by suppressing HOXA9-dependent gene expression and inducing apoptosis in the human acute myeloid cell line, THP-1. Neriifolin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells and can be used in prostate cancer research.
    • $148
    In Stock
    Size
    QTY
    DB818 dihydrochloride
    T200478
    DB818 dihydrochloride is the dihydrochloride salt form of DB818. It acts as an inhibitor of Homeobox A9 (HOXA9). By reducing the formation of the HOXA9-DNA complex, DB818 dihydrochloride inhibits the growth of AML cell lines OCI/AML3, MV4-11, and THP-1 and induces cell apoptosis (apoptosis).
    • Inquiry Price
    Backorder
    Size
    QTY
    MI-2-2
    MI22, MI 2 2
    T280361454920-20-7
    MI-2-2 is an inhibitor of bivalent protein-protein interaction between menin and MLL with an IC50 of 46 nM. MI-2-2 binds to menin with Kd of 22 nM.
    • $58
    In Stock
    Size
    QTY
    DB1055
    T68487869767-86-2
    DB1055 is a novel HOXA9 Transcription Factor Inhibitor, dedemonstrating for the first time the propensity of sequence-selective DNA ligands to inhibit HOXA9/DNA binding.
    • $1,520
    6-8 weeks
    Size
    QTY
    Dot1L-IN-1 TFA
    T73637
    Dot1L-IN-1 TFA is a potent and selective Dot1L inhibitor, with a K i of 2 pM and an IC50 of <0.1 nM. It effectively inhibits H3K79 dimethylation (IC50 = 3 nM) and suppresses HoxA9 promoter activity (IC50 = 17 nM) in HeLa and Molm-13 cells, respectively [1].
    • Inquiry Price
    Backorder
    Size
    QTY
    WM-3835
    T91022229025-70-9
    WM-3835 is a novel and high-specific small molecule inhibitor of Lysine Acetyltransferase 7 (KAT7, MYST2, HBO1) , able to potently suppressed OS cell proliferation and migration, and leads to apoptosis activation.
    • $31
    In Stock
    Size
    QTY